Sign in
CompletedNo phase

The DETECT HCV Screening Trial

Key facts

Who runs it
Denver Health and Hospital Authority
Where
Baltimore, Denver, and Jackson, United StatesSee the 3 sites
Trial code
Status
Completed
People taking part
147,533 people enrolled
Started
20 Nov 2019
Ended
31 Jan 2024
Type of study
Interventional, 2 groups
Treatments tested
  • HCV Screening
Record updated
6 February 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Present to EDs during study enrollment period
  • Clinically stable per screening nurse or physician assessment
  • Able to provide consent for medical care

Who cannot take part

  • Are unable to consent for care (i.e., altered mentation, critical illness, or injury)
  • Self-Identify as already living with HCV
  • Younger than 18 years of age
  • Have already participated in the trial

Where in United States

  • Johns Hopkins UniversityBaltimore, United States
  • Denver Health Medical CenterDenver, United States
  • University of Mississippi Medical CenterJackson, United States

About the trial

What the trial wants to find out

The investigators propose to compare the effectiveness of nontargeted rapid opt-out hepatitis C (HCV) screening versus targeted rapid opt-out HCV screening using recommended risk characteristics in multiple urban emergency departments (EDs) across the United States (Aim 1 - "Screening Trial").

The 2 groups in the trial

  • Nontargeted ScreeningOther group

    The nontargeted HCV screening arm will consist of implementing non-risk-based rapid opt-out HCV screening.

    Treatment: HCV Screening

  • Targeted ScreeningOther group

    The targeted HCV screening arm will consist of implementation of risk-based rapid opt-out HCV screening using current recommendations for HCV screening by the CDC, USPSTF, and AASLD-IDSA. Targeted HCV screening will consist of offering HCV testing to those identified with the following specific risk characteristics, adapted from the above recommendations: born between 1945 - 1965 ("birth cohort"); injection drug use (IDU); intranasal drug use;tattoo or piercing in an unregulated setting; or blood transfusion or organ recipient before 1992.

    Treatment: HCV Screening

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for HCV Trial
Publications
Record updated
6 February 2025